Canakinumab - Novartis
At a glance
- Drug Originator Novartis
- Drug Class Anti-inflammatories; Antianaemics; Antigouts; Antihyperglycaemics; Antineoplastics; Antirheumatics; Cardiovascular therapies; Eye disorder therapies; Heart failure therapies; Immunotherapies; Monoclonal antibodies; Vascular disorder therapies
- Mechanism of Action Interleukin 1 beta inhibitors
- USA Patent Applicants NOVARTIS PHARMS
- USA Patents 58
- BLAs 1
- International Patents 309

Disclaimer